BrainStorm touts preclinical work; Antisoma encouraged by mid-stage AML trial;

> BrainStorm Cell Therapeutics says that preclinical work on its adult stem cell therapy for spinal cord injuries has demonstrated efficacy in rats. BrainStorm release 

> Antisoma says that encouraging results from a Phase II study of a new therapy for AML has convinced researchers to increase the dosage in the next mid-stage trial. Release

> Neurobiological Technologies announced that Paul E. Freiman, president and chief executive officer (CEO), has announced his intent to retire on December 31, 2008. Release

> A federal judge is urging Eli Lilly to negotiate a worldwide settlement with Zyprexa plaintiffs, who are asking for some $7.7 billion. Zyprexa report

> Where's the growth? According to a Financial Times survey, a quarter of pharma execs agree that diversifying away from medications and stepping up sales in emerging markets are the way to go. Report

> Good news for makers of cholesterol meds: The market has just expanded. For the first time, the American Academy of Pediatrics is recommending that kids as young as 8 years old be given cholesterol drugs in hopes of preventing future heart disease. Report

> A German company is snapping up APP Pharmaceuticals in a deal worth more than $4.6 billion. Report

And Finally... A woman in southern Ontario is one of the first cases in Canada of a rare neurological syndrome in which a person starts speaking with a different accent, McMaster University researchers report in the July issue of the Canadian Journal of Neurological Sciences. Release

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.